"Contemporary Epidemiology of Hepatocellular Carcinoma in the US," presented by Hashem El-Serag, MD, PhD. Dr. El-Serag is the Margaret M. and Albert B. Alkek Professor and Chair Department of Medicine Baylor College of Medicine. His research focuses on the clinical epidemiology and outcomes of several digestive disorders, including Barrett's esophagus, esophageal adenocarcinoma, hepatocellular carcinoma, and hepatitis C. He has obtained over 55 funded research grants including those from NIH, VA, and Cancer Prevention Research Institute of Texas (CPRIT). #cancer #epidemiology #carcinoma

Learn more about our Frontiers in Oncology series: https://med.stanford.edu/cancer/training/events/frontiers/12012020.html
Learn more about the Stanford Cancer Institute: https://med.stanford.edu/cancer

Follow the Stanford Cancer Institute
LinkedIn: https://www.linkedin.com/company/stanford-cancer/
Twitter: https://twitter.com/StanfordCancer
Subscribe to the Stanford Cancer Institute: https://www.youtube.com/@stanfordcancerinstitute/
------------------------------------------------------------------------------------------------------------------------------------------------------
0:00 Introduction
0:04 Stanford Cancer Institute Presents Frontiers in Oncology
6:30 Liver Cancer Mortality
7:48 SAS Essentials Mastering SAS for Data Analytics
9:49 The New England Journal of Medicine
16:06 Risk of HCC after DAA Treatment
27:33 HBV: Risk Factors for Progression to CL and HCC
33:25 Obesity/Diabetes and HCC Distal vs. Proximal Associations
49:10 HCC Risk Factors Prevalence, Relative Risk Estimates, and Population Attributable Fraction
50:30 Prevalence of Risk Factors vs Risk
52:18 Summary